NCT01745237View on ClinicalTrials.gov

Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

RecruitingOBSERVATIONAL

Enrollment

27,000

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

June 30, 2032

Study Completion Date

June 30, 2032

Conditions

Sarcoidosis

Trial Locations (1)

27707

RECRUITING

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT01745237 - Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis | Biotech Hunter | Biotech Hunter